Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Goodwill & Intangibles (2016 - 2025)

Avanos Medical (AVNS) has disclosed Goodwill & Intangibles for 13 consecutive years, with $512.7 million as the latest value for Q4 2025.

  • Quarterly Goodwill & Intangibles fell 9.72% to $512.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $512.7 million through Dec 2025, down 9.72% year-over-year, with the annual reading at $512.7 million for FY2025, 9.72% down from the prior year.
  • Goodwill & Intangibles hit $512.7 million in Q4 2025 for Avanos Medical, down from $516.4 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $1.1 billion in Q1 2022 to a low of $486.6 million in Q2 2025.
  • Historically, Goodwill & Intangibles has averaged $891.7 million across 5 years, with a median of $989.8 million in 2022.
  • Biggest five-year swings in Goodwill & Intangibles: rose 14.8% in 2022 and later tumbled 52.32% in 2025.
  • Year by year, Goodwill & Intangibles stood at $883.7 million in 2021, then rose by 12.54% to $994.5 million in 2022, then rose by 4.13% to $1.0 billion in 2023, then crashed by 45.16% to $567.9 million in 2024, then dropped by 9.72% to $512.7 million in 2025.
  • Business Quant data shows Goodwill & Intangibles for AVNS at $512.7 million in Q4 2025, $516.4 million in Q3 2025, and $486.6 million in Q2 2025.